127
Participants
Start Date
February 18, 2025
Primary Completion Date
January 31, 2028
Study Completion Date
January 31, 2028
LY4006896
Administered intravenously (IV)
Placebo
Administered IV
NOT_YET_RECRUITING
Progressive Medical Research, Port Orange
NOT_YET_RECRUITING
K2 Medical Research, LLC, The Villages
NOT_YET_RECRUITING
K2 Medical Research, LLC, Maitland
NOT_YET_RECRUITING
Charter Research, Orlando
NOT_YET_RECRUITING
Aqualane Clinical Research, Naples
NOT_YET_RECRUITING
QUEST Research Institute, Farmington Hills
RECRUITING
PPD Development, LP, Austin
NOT_YET_RECRUITING
Collaborative Neuroscience Network - CNS, Los Alamitos
NOT_YET_RECRUITING
Collaborative Neuroscience Network - CNS, Los Alamitos
NOT_YET_RECRUITING
Evergreen Health Research, Kirkland
NOT_YET_RECRUITING
Charter Research, The Villages
NOT_YET_RECRUITING
P-One Clinic, Hachiōji
NOT_YET_RECRUITING
Oita University Hospital, Yufu
Eli Lilly and Company
INDUSTRY